Timothy J. Price

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Penelope Schofield

Swinburne University of Technology

AUSTRALIA

View details

David Roder

University of South Australia

AUSTRALIA

View details

Christos S. Karapetis

AUSTRALIA

View details

Belinda Lee

Oncologist & Head of Cancer Clinical Trials Unit

AUSTRALIA

View details

John R. Zalcberg

AUSTRALIA

View details

Fiona Day

Conjoint Associate Professor

Newcastle University

AUSTRALIA

View details

Eleonora Feletto

University of Sydney

AUSTRALIA

View details

Graeme Young

Flinders University

AUSTRALIA

View details

Lorraine Chantrill

Head of Department

AUSTRALIA

View details

Nick Pavlakis

University of Sydney

AUSTRALIA

View details

Jean-Yves Blay

University Professor, Medical Oncology

Université Claude Bernard Lyon 1 - Domaine de Rockefeller

FRANCE

View details

Qingwei Luo

Associate Professor

Biology Centre

AUSTRALIA

View details

Ishraq Murshed

Government of South Australia

AUSTRALIA

View details

Desmond Yip

Professor (Full)

Australian National University Medical School

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Timothy J. Price

Research Interests

Explore related searches

Contact this professor

Articles (20)

Total neoadjuvant therapy in early‐onset rectal cancer: A multicentre prospective cohort study

Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial

A phase 1 study to assess the safety, tolerability and effectiveness of PV-10 (Rose Bengal Sodium) in neuroendocrine tumours metastatic to the liver

The South Australian 177Lu-DOTATATE peptide receptor radionuclide therapy service: an 11-year review of toxicity, health-related quality of life, and survival

A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours

Re-evaluating population-level screening recommendations to address increasing early-onset colorectal cancer rates in Australia: a modelling study

Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis

Clinical and quality of life outcomes with trifluridine/tipiracil: PRECONNECT and TALLISUR studies

Primary site and treatment impact in unresectable metastatic colorectal cancer

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy

Circulating tumour DNA and MRI circumferential resection margin are key prognostic indicators for survival in rectal cancer

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial

The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours.

Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry

Insights From the IDEA Collaboration: Are They Enough?

Immunotherapy use in oesophagogastric cancers—a review of the literature

Insights From the IDEA Collaboration: Are They Enough?

Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty

Targeting Mutated KRAS Genes to Treat Solid Tumours

Collaborators (14)

Penelope Schofield

David Roder

Christos S. Karapetis

Belinda Lee

John R. Zalcberg

Fiona Day

Eleonora Feletto

Graeme Young

Lorraine Chantrill

Nick Pavlakis

Jean-Yves Blay

Qingwei Luo

Ishraq Murshed

Desmond Yip

Make your next move.